Return to search

Pharmacokinetics and pharmacodynamics of dexmedetomidine in horses

An ideal dexmedetomidine protocol has yet to be determined for standing sedation in horses. It was hypothesized that an intravenous (IV) bolus followed by continuous rate infusion (CRI) dexmedetomidine would have a quicker increase in plasma concentrations compared to repeated intramuscular (IM) injections. In a cross-over design, eight adult, female horses were randomly placed in two groups: the CRI group (IV bolus dexmedetomidine at 0.005 mg/kg followed by a CRI at 0.01 mg/kg/hr for 15 minutes then 0.005 mg/kg/hr for 60 minutes) and the IM group (dexmedetomidine at 0.01 mg/kg, followed by 0.005 mg/kg in 30-minute intervals for 60 minutes). Analgesia was evaluated using a mechanical pressure threshold device. Intravenous dexmedetomidine produced faster onset of sedation and increased pressure threshold compared to IM administration. Individual horses had a large variability in dexmedetomidine plasma concentrations between CRI and IM administration.

Identiferoai:union.ndltd.org:MSSTATE/oai:scholarsjunction.msstate.edu:td-6141
Date30 April 2021
CreatorsShane, Sarah E.
PublisherScholars Junction
Source SetsMississippi State University
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
SourceTheses and Dissertations

Page generated in 0.002 seconds